Literature DB >> 26684877

Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.

Anamarija M Perry1, Jacques Diebold2, Bharat N Nathwani3, Kenneth A MacLennan4, Hans K Müller-Hermelink5, Martin Bast6, Eugene Boilesen7, James O Armitage6, Dennis D Weisenburger3.   

Abstract

Comparative data regarding the distribution of non-Hodgkin lymphoma (NHL) subtypes in North Africa, the Middle East and India (NAF/ME/IN) is scarce in the literature. In this study, we evaluated the relative frequencies of NHL subtypes in this region. Five expert haematopathologists classified 971 consecutive cases of newly-diagnosed NHL from five countries in NAF/ME/IN. After review, 890 cases (91·7%) were confirmed to be NHL and compared to 399 cases from North America (NA). The male-to-female ratio was significantly higher in NAF/ME/IN (1·8) compared to NA (1·1; P< 0·05). The median ages of patients with low-grade (LG) and high-grade (HG) B-NHL in NAF/ME/IN (56 and 52 years, respectively) were significantly lower than in NA (64 and 68 years, respectively). In NAF/ME/IN, a significantly lower proportion of LG B-NHL (28·4%) and a higher proportion of HG B-NHL (58·4%) were found compared to NA (56·1% and 34·3%, respectively). Diffuse large B-cell lymphoma was more common in NAF/ME/IN (49·4%) compared to NA (29·3%), whereas follicular lymphoma was less common in NAF/ME/IN (12·4%) than in NA (33·6%). In conclusion, we found significant differences in NHL subtypes and clinical features between NAF/ME/IN and NA. Epidemiological studies are needed to better understand the pathobiology of these differences.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Middle East; Non-Hodgkin lymphoma; North Africa; epidemiology

Mesh:

Year:  2015        PMID: 26684877     DOI: 10.1111/bjh.13876

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.

Authors:  Anamarija M Perry; Jacques Diebold; Bharat N Nathwani; Kenneth A MacLennan; Hans K Müller-Hermelink; Martin Bast; Eugene Boilesen; James O Armitage; Dennis D Weisenburger
Journal:  Haematologica       Date:  2016-06-27       Impact factor: 9.941

2.  Diffuse large B-cell lymphoma: An institutional analysis.

Authors:  Ajay Gogia; Chandan K Das; Lalit Kumar; Atul Sharma; Akash Tiwari; M C Sharma; Soumya Mallick
Journal:  South Asian J Cancer       Date:  2018 Jul-Sep

3.  Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: association with R-CHOP responsiveness.

Authors:  Mahmoud A Senousy; Aya M El-Abd; Raafat R Abdel-Malek; Sherine M Rizk
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

4.  Subtype distribution of lymphomas in northwestern Iran: a retrospective analysis of 659 cases according to World Health Organization classification.

Authors:  Javad Jalili; Amir Vahedi; Amin Danandehmehr; Parya Aynechi; Ali Esfahani; Yousef Roosta; Hooman Nateghian; Amirhosein Ghafouri Asbagh; Fateme Hajihoseinlou
Journal:  BMC Cancer       Date:  2022-10-12       Impact factor: 4.638

5.  Extranodal lymphoma arising within the maxillary alveolus: a systematic review.

Authors:  David MacDonald; Sean Lim
Journal:  Oral Radiol       Date:  2017-12-08       Impact factor: 1.852

6.  Spectrum of lymphoma in Bahrain. A retrospective analysis according to the World Health Organization classification.

Authors:  Eman A Aljufairi; Sara M George; Safa A Alshaikh; Ameera A Radhi; Rawia M Mohamed
Journal:  Saudi Med J       Date:  2018-07       Impact factor: 1.484

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.